J. Li

发表

Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk

P. Hall, K. Humphreys, Z. Aitken, 2014, British Journal of Cancer.

Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer.

C. Wang, Jing Li, T. Wang, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers.

P. Hall, M. Eriksson, J. Bergh, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Prevalence of BRCA 1 mutations and responses to neoadjuvant chemotherapy among BRCA 1 carriers and non-carriers with triple-negative breast cancer

C. Wang, J. Zhang, Y. Wang, 2015 .

Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancers

Y. Li, X. Chen, T. Wang, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[Impact of the response of primary tumor to preoperative chemotherapy and anti-HER2 therapy on survival of HER2-positive breast cancer patients].

T. Wang, Z. Fan, T. Fan, 2016, Zhonghua yi xue za zhi.

Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy.

S. Narod, D. Deng, C. Wang, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer.

Jingmei Li, K. Czene, P. Hall, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple‐negative or familial breast cancer

T. Wang, Z. Fan, T. Fan, 2018, Clinical genetics.

Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer.

Y. Xu, T. Wang, Z. Fan, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers.

P. Hall, M. Eriksson, J. Bergh, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium

Kristen S Purrington, P. Fasching, A. Ashworth, 2014, British Journal of Cancer.

Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment.

Lei He, Y. Wu, Y. Xu, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

HER2 and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.

Z. Li, Y. Liu, L. Yao, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Association between the HER 2 Ile 655 Val polymorphism and response to trastuzumab in women with operable primary breast cancer

Y. Xu, T. Wang, Z. Fan, 2014 .

Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapy

T. Wang, Z. Fan, T. Ouyang, 2020, Clinical and Translational Oncology.